Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jennifer R. Elliott"'
Autor:
Joanne Valeriano-Marcet, Amy Joseph, Ted R. Mikuls, J. Rodrigues, Thomas Olenginski, Cynthia Weaver, Salahuddin Kazi, Pamela E. Prete, Ciaran S. Phibbs, James R. O'Dell, Peter D. Kent, Keri Hannagan, Samardeep Gupta, Jay E. Persselin, Keith K. Colburn, Erika Holmberg, Virginia Reddy, David I. Daikh, Joseph Fanciullo, Liam Martin, Gail S. Kerr, Aslam H. Anis, Lynne Peterson, Sarah Leatherman, Karen S. Kolba, Hani El-Gabalawy, Raymond Hausch, Andrew Chow, Andreas M. Reimold, Vivian P. Bykerk, William T. Ayoub, Huiying Sun, Gilles Boire, John M. Davis, David Pugliese, H. Ralph Schumacher, Edward C. Keystone, Mary Brophy, Mahfooz Peshimam, C. Kent Kwoh, Jennifer R. Elliott, J. Carter Thorne, Maren L. Mahowald, Nick Bansback
Publikováno v:
Annals of internal medicine. 167(1)
The RACAT (Rheumatoid Arthritis Comparison of Active Therapies) trial found triple therapy to be noninferior to etanercept-methotrexate in patients with active rheumatoid arthritis (RA).To determine the cost-effectiveness of etanercept-methotrexate v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d68e3161a911718991c2494b41cae48e
https://pubmed.ncbi.nlm.nih.gov/28554192
https://pubmed.ncbi.nlm.nih.gov/28554192
Autor:
Munther A. Khamashta, Silvia Ruiz-Garcia, Jonathan S. Coblyn, Eliza F. Chakravarty, John G. Hanly, Karen H. Costenbader, Bonnie L. Bermas, Jigna Liu, Kaleb Michaud, Paul R. Fortin, Michelle Petri, Iris Navarro, Patricia A. Fraser, Maria Teresa Perez-Rodriguez, Graciela S. Alarcón, Susan Manzi, Martha L. Sanchez, Tabitha Turner-Stokes, Timothy S. Shaver, Frederick Wolfe, Elena Massarotti, Robert S. Katz, Jennifer R. Elliott, Elizabeth W. Karlson, Peter H. Schur
Publikováno v:
Arthritis Care & Research. 62:559-568
Objective The Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) is a validated instrument for assessing organ damage in systemic lupus erythematosus (SLE). Trained physicians must complete it, thus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c6af226f1aff199d25980790de94f5e
https://doi.org/10.1002/acr.20193
https://doi.org/10.1002/acr.20193
Publikováno v:
Current Rheumatology Reports. 11:241-247
Cardiovascular disease (CVD) has emerged as a leading cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Growing evidence suggests that inflammation plays a key role in the pathogenesis of atherosclerosis from initi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a0f80e28387aa9af57259223112061c
https://doi.org/10.1007/s11926-009-0034-0
https://doi.org/10.1007/s11926-009-0034-0
Publikováno v:
Current Rheumatology Reports. 9:125-130
With improved therapeutic advances in the care of systemic lupus erythematosus patients, cardiovascular disease has emerged as a leading cause of death. Premature atherosclerosis in lupus patients is probably an interaction between traditional cardio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b92dbd18d6ff920f9ddecf87a1a365a
https://doi.org/10.1007/s11926-007-0006-1
https://doi.org/10.1007/s11926-007-0006-1
Autor:
Jennifer R. Elliott, Ted R. Mikuls, Cynthia Anderson Weaver, Rob D. Leff, James R. O'Dell, Jack A. Mallek, Kent M. Blakely, Raymond Hausch, Scott L. Glickstein
Publikováno v:
Arthritis & Rheumatism. 54:621-627
Objective To compare the efficacy of doxycycline plus methotrexate (MTX) versus MTX alone in the treatment of early seropositive rheumatoid arthritis (RA), and to attempt to differentiate the antibacterial and antimetalloproteinase effects of doxycyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0ca7a00ee606d231e49ad71eb689278
https://doi.org/10.1002/art.21620
https://doi.org/10.1002/art.21620
Publikováno v:
Journal of Allergy and Clinical Immunology. 139:AB5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f93fd753fa490b18b6a8a291e72b0bf
https://doi.org/10.1016/j.jaci.2016.12.070
https://doi.org/10.1016/j.jaci.2016.12.070
Autor:
Rosalind Ramsey-Goldman, Mehret S Birru, Zheni Avram, Jennifer R. Elliott, Kim Sutton-Tyrrell, Penny Shaw, Trina Thompson, Abdus Sattar, Amy H. Kao, Linda C. Santelices, Susan Manzi, Apinya Lertratanakul
Patients with systemic lupus erythematosus (SLE) are at increased risk for cardiovascular (CV) disease. The aim of this study was to investigate the association between subclinical CV disease as measured by carotid intima-media thickness (IMT) and pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16915cc83847d3a8d932034db049e1b
https://europepmc.org/articles/PMC3779482/
https://europepmc.org/articles/PMC3779482/
Autor:
Sara Kaprove Penn, Mary Chester M. Wasko, Amy H. Kao, Laura L. Schott, Jennifer R. Elliott, Lewis H. Kuller, Susan Manzi, Frederico G.S. Toledo
Objective.To determine the relationship between current hydroxychloroquine (HCQ) use and 2 indicators of glycemic control, fasting glucose and insulin sensitivity, in nondiabetic women with systemic lupus erythematosus (SLE) or rheumatoid arthritis (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec42c1c12f72ec900d3581ecacdce52
https://europepmc.org/articles/PMC3457696/
https://europepmc.org/articles/PMC3457696/
Autor:
Jennifer R. Elliott, Susan Manzi
Publikováno v:
Best practiceresearch. Clinical rheumatology. 23(4)
With improved treatment modalities and survival rates, patients with systemic lupus erythematosus live longer and their co-morbidities have become more apparent. Of great concern is cardiovascular disease, which has become a leading cause of death. L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e649e43a26a1896c9e2817d5c6cfaf15
https://pubmed.ncbi.nlm.nih.gov/19591779
https://pubmed.ncbi.nlm.nih.gov/19591779
Autor:
Michael M. Ward, Mary Chester M. Wasko, Michael E. Luggen, Jennifer R. Elliott, Helen B. Hubert, James F. Fries, Vijaya B. Lingala
Publikováno v:
JAMA. 298(2)
ContextHydroxychloroquine, a commonly used antirheumatic medication, has hypoglycemic effects and may reduce the risk of diabetes mellitus.ObjectiveTo determine the association between hydroxychloroquine use and the incidence of self-reported diabete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15098e50746687c676f3e82cfe596f08
https://pubmed.ncbi.nlm.nih.gov/18042914
https://pubmed.ncbi.nlm.nih.gov/18042914